Nanotech Investing Anixa Biosciences Awarded Key U.S. Patent Expanding Breast Cancer Vaccine IP Protection into 2040s
Nanotech Investing Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Tuesday, November 11, 2025
Nanotech Investing Anixa Biosciences Announces Execution of Data Transfer Agreement with Cleveland Clinic
Nanotech Investing Anixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference
Nanotech Investing Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology
Nanotech Investing Anixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial
Nanotech Investing Cleveland Clinic to Present Final Results of Phase 1 Clinical Trial for Anixa Biosciences' Breast Cancer Vaccine at 2025 San Antonio Breast Cancer Symposium
Nanotech Investing Anixa Biosciences and Moffitt Cancer Center Complete Dosing of Fourth Cohort in Ovarian Cancer CAR-T Clinical Trial; Multiple Patients Surpassing Median Expected Survival
Nanotech Investing Anixa Biosciences Announces Time Change for Presentation at the H.C. Wainwright 27th Annual Global Investment Conference
Nanotech Investing Anixa Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Nanotech Investing Anixa Biosciences Receives Notice of Allowance from Chinese National Intellectual Property Administration for Patent Covering Breast Cancer Vaccine Technology
Nanotech Investing Anixa Biosciences Announces Treatment of Second Patient in Fourth Cohort of Ovarian Cancer CAR-T Clinical Trial
Silver Dollar Discovers New Mineralized Zone at the Nora Silver-Gold Project and Receives Drill Permit
Terra Clean Closes the Acquisition of the Past Producing Uranium Claims in San Rafael Swell, Utah, United States
CHARBONE Confirms Construction Schedule on Track at Sorel-Tracy and Announces the Imminent Start of Equipment Installation Phase
